Part 1: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Ascending Single Dose and Food Influence Study of QGC001 Administered Orally To Healthy Adult Subjects, Part 2: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Ascending Multiple Dose Study of QGC001 Administered Orally To Healthy Adult Subjects.
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Firibastat (Primary)
- Indications Essential hypertension
- Focus Adverse reactions
- Sponsors Quantum Genomics
- 18 Jul 2013 New source identified and integrated: ClincalTrials.gov record.
- 18 Jul 2013 Status changed from recruiting to completed, as reported by the ClincialTrials.gov record.
- 18 Oct 2012 New trial record